On and off responses of the photopic fullfield ERG in normal subjects and glaucoma patients.
Recent studies suggest a diagnostic value of the photopic negative response (PhNR) with a long-duration stimulus. The aim of this study was to record the on and off responses of the photopic fullfield electroretinogram (ERG) in normal subjects and glaucoma patients. We focused on different waves of the responses after onset and offset of the long-duration stimulus ERG. Photopic fullfield ERGs were recorded in response to a white bright LED flash on a white 20 cd/m(2) background. Stimulus luminances were 40, 60 and 80 cd/m(2). Responses were averaged using a flash duration of 240 ms and an offset period of 500 ms. We examined 19 healthy subjects, 27 patients with glaucomatous optic disc atrophy and 7 ocular hypertensive patients. The amplitudes and implicit times of the on and off responses of the human ERG depended on flash luminance. Comparing patients with glaucoma and healthy subjects for the 60 cd/m² flash, there was a significant change in the PhNRs (at onset: P < 0.01, at offset: P < 0.001) of the d-wave and of the i-wave at offset (P < 0.01). No significant difference was found for peak times of the fullfield ERG and for a- and b-wave amplitudes. PhNR amplitudes were significantly correlated with mean thickness of retinal nerve fibre layer as measured with OCT. In comparison with the normal photopic long-flash ERG, glaucoma patients showed changes in the PhNR amplitude following stimulus onset and in waves following stimulus offset.
Department of Ophthalmology and University Eye Hospital, Friedrich-Alexander University of Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany. folkert.horn@uk-erlangen.de
Folkert K
FK
Horn
Kristina
K
Gottschalk
Christian Y
CY
Mardin
Gobinda
G
Pangeni
Anselm G
AG
Jünemann
Jan
J
Kremers
D000368:Aged; D001284:Atrophy; D015331:Cohort Studies; D055253:Color Vision; D004596:Electroretinography / Q000379:methods*; D005260:Female; D005901:Glaucoma / Q000175:diagnosis* / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology; D009898:Optic Disk / Q000473:pathology; D010775:Photic Stimulation / Q000379:methods; D012160:Retina / Q000473:pathology
Doc Ophthalmol. 2009 Feb;118(1):69-77
19030905
Br J Ophthalmol. 2010 Feb;94(2):202-8
19692386
Ophthalmologica. 2009;223(6):362-9
19590251
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4818-28
17898309
Graefes Arch Clin Exp Ophthalmol. 1988;226(6):522-30
3209079
Doc Ophthalmol. 2006 Jan;112(1):1-11
16633720
Doc Ophthalmol. 2001 Jan;102(1):19-30
11475363
Doc Ophthalmol. 2008 Jul;117(1):37-46
18026866
Invest Ophthalmol Vis Sci. 1999 May;40(6):1124-36
10235545
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1216-22
19850843
Invest Ophthalmol Vis Sci. 2001 May;42(6):1266-72
11328738
Vision Res. 2006 Mar;46(5):658-64
16039691
Doc Ophthalmol. 2008 Sep;117(2):147-54
18273658
Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3827-37
15452095
Graefes Arch Clin Exp Ophthalmol. 2002 Aug;240(8):658-65
12192460
Invest Ophthalmol Vis Sci. 2008 May;49(5):2201-7
18436853
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2205-11
10892864
Arch Ophthalmol. 2004 Mar;122(3):341-6
15006846
Surv Ophthalmol. 1999 Jan-Feb;43(4):293-320
10025513
Invest Ophthalmol Vis Sci. 2001 Feb;42(2):514-22
11157891
Trans Am Ophthalmol Soc. 1993;91:701-73
8140708
Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2797-810
10937600
Doc Ophthalmol. 2006 Jul;113(1):53-9
16944088
Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3544-50
18441308
Vet Ophthalmol. 2004 May-Jun;7(3):189-92
15091327
Doc Ophthalmol. 2001 Jul;103(1):1-12
11678156
Jpn J Ophthalmol. 2000 Jan-Feb;44(1):20-8
10698021
Doc Ophthalmol. 2004 Mar;108(2):107-14
15455793
Doc Ophthalmol. 2006 Jul;113(1):43-52
16906409
Invest Ophthalmol Vis Sci. 1994 Feb;35(2):635-45
8113014
Surv Ophthalmol. 2008 Jan-Feb;53(1):16-40
18191655